Galatea Bio's mission is to drive groundbreaking discoveries in healthcare by pairing genetic diversity with cutting-edge data analytics.
Galatea Bio has raised $8.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.
Galatea Bio's investors include Founder Collective, F-Prime Capital, Digitalis Ventures, Helios Investment Partners, Alexandria Real Estate Equities.
Galatea Bio is headquartered in Miami Lakes, United States.
Galatea Bio's mission is to drive groundbreaking discoveries in healthcare by pairing genetic diversity with cutting-edge data analytics.
Galatea Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Galatea Bio — Funding & Investors." VCBacked, March 27, 2025, https://www.vcbacked.co/company/galatea-bio. Accessed July 21, 2026.
VCBacked. (2025). Galatea Bio — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/galatea-bio
{{cite web |title=Galatea Bio — Funding & Investors |url=https://www.vcbacked.co/company/galatea-bio |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated